Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Cancers Associated with Specific Viruses
Can Screening for Cancer-Causing Viruses Predict Progression and Treatment Outcome?
Viral Safety Copes with Complexity
Viral Clearance Calls for Bioprocess Engineers to Implement Control Strategies
Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
For full access to this article login to GEN Select now.
Advertorial: Accelerating Therapeutic Development and Manufacturing
Using a Single High-Performance Delivery Platform for Cell Engineering
- Identify more relevant and efficacious candidates faster, more cost-effectively, and with reduced risk. These goals are common to researchers developing therapeutics of all modalities, whether small molecules, proteins and antibodies, or cell-based medicines. Flexible, efficient cell engineering is central to attaining these goals. MaxCyte’s delivery platform accelerates the discovery/development, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.